• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 295/15 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Patent holdings for IPC class C07D 295/15

Total number of patents in this class: 357

10-year publication summary

35
19
27
24
22
32
41
30
32
16
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
The Board of Trustees of the University of Illinois
2751
9
Tetraphase Pharmaceuticals, Inc.
52
9
The Board of Regents of the University of Texas System
2296
9
Novartis AG
10262
6
Pharmatrophix, Inc.
25
5
Ramot at Tel-Aviv University Ltd.
1543
5
University of Tennessee Research Foundation
763
5
Yissum Research Development Company of The Hebrew University of Jerusalem Ltd.
1352
5
Sanofi
4301
5
Beam Therapeutics Inc.
289
5
Contemporary Amperex Technology (Hong Kong) Limited
4015
5
Rohm and Haas Company
2951
4
Dow Global Technologies LLC
10944
4
President and Fellows of Harvard College
6094
4
JSR Corporation
2554
4
Acuitas Therapeutics Inc.
137
4
The Cooper Health System
46
4
SRI International
992
4
West China Hospital, Sichuan University
237
4
Acelot, Inc.
16
4
Other owners 253